tiprankstipranks
Trending News
More News >
Belite Bio, Inc. ADR (BLTE)
NASDAQ:BLTE
US Market

Compare Belite Bio, Inc. ADR (BLTE) vs. Competitors

Compare
59 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Belite Bio, Inc. ADR
$154.59
$6.08B
-69.12
128.24%
7 Buy
0 Hold
0 Sell
Strong Buy
Denali Therapeutics
$20.17
$3.20B
-5.65
38.06%
12 Buy
1 Hold
0 Sell
Strong Buy
Kiniksa Pharmaceuticals
$46.08
$3.53B
51.87
93.53%
6 Buy
0 Hold
0 Sell
Strong Buy
Beam Therapeutics
$24.63
$2.51B
-34.27
7.70%
12 Buy
2 Hold
0 Sell
Strong Buy
Harmony Biosciences Holdings
$27.72
$1.60B
13.56
-20.57%
4 Buy
3 Hold
1 Sell
Moderate Buy
Centessa Pharmaceuticals
$27.06
$3.64B
-14.82
66.11%
7 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
BLTE
Belite Bio, Inc. ADR
154.59
87.65
130.94%
DNLI
Denali Therapeutics
20.17
5.41
36.65%
KNSA
Kiniksa Pharmaceuticals
46.08
22.67
96.84%
BEAM
Beam Therapeutics
24.63
0.62
2.58%
HRMY
Harmony Biosciences Holdings
27.72
-6.52
-19.04%
CNTA
Centessa Pharmaceuticals
27.06
10.43
62.72%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts